Webinar On Demand: Shockwave IVL Within Non-Surgical Facilities

Learn How Coronary IVL is Currently Utilized Within Non-Surgical Facilities

 

Want to learn more about Coronary IVL’s place within existing facilities lacking surgical cardiac backup? Cardiovascular Business and Shockwave Medical is excited to present this on demand webinar titled: No Surgical Backup? No Problem. This webinar consists of an expert panel who provide real-world insights and implications of Coronary IVL usage within non-surgical facilities. Topics within this event include a review of the recent SCAI Expert Consensus Document regarding PCI within non-surgical facilities, an introduction to Shockwave IVL, and a real-world clinical and administrational perspective of Coronary IVL within an existing non-surgical facility. A fantastic roundtable discussion and Q+A close the webinar with additional insights regarding Coronary IVL within these important facilities.

 

The webinar and additional information regarding Coronary IVL and non-surgical facilities can be found at the links below.

 

Watch the video:

 

 

 

Additional Resources:

 

  1. No Surgical Backup? No Problem. Learn about the new SCAI Guidance

 

  1. Read Dr. B. Clay Sizemore's Thoughts on IVL in Hospitals with No Surgical Backup
  2.  
  3. Shockwave IVL Coronary Reimbursement Information
  4.  
  5. Shockwave C2 Product Information

 

twitter-logo-vector-circle-beautiful-logo-google-search

 

To learn more and stay in touch, follow @ShockwaveIVL on Twitter.

 

 

 

 

Drs. Alex Truesdell, Poonam Velagapudi, Clay Sizemore, and Chris Newman are paid consultants for Shockwave Medical.

 

Important Safety Information

 

Please contact your local Shockwave representative for specific country availability and refer to the Shockwave C2 instructions for use containing important safety information.

 

Rx only

 

Indications for Use—The Shockwave Intravascular Lithotripsy (IVL) System with the Shockwave C2 Coronary IVL Catheter is indicated for lithotripsy-enabled, low-pressure balloon dilatation of severely calcified, stenotic de novo coronary arteries prior to stenting.

 

Contraindications—The Shockwave C2 Coronary IVL System is contraindicated for the following: This device is not intended for stent delivery. This device is not intended for use in carotid or cerebrovascular arteries.

 

Warnings— Use the IVL Generator in accordance with recommended settings as stated in the Operator’s Manual. The risk of a dissection or perforation is increased in severely calcified lesions undergoing percutaneous treatment, including IVL. Appropriate provisional interventions should be readily available. Balloon loss of pressure was associated with a numerical increase in dissection which was not statistically significant and was not associated with MACE.  Analysis indicates calcium length is a predictor of dissection and balloon loss of pressure.  IVL generates mechanical pulses which may cause atrial or ventricular capture in bradycardic patients. In patients with implantable pacemakers and defibrillators, the asynchronous capture may interact with the sensing capabilities. Monitoring of the electrocardiographic rhythm and continuous arterial pressure during IVL treatment is required.  In the event of clinically significant hemodynamic effects, temporarily cease delivery of IVL therapy.

 

Precautions— Only to be used by physicians trained in angiography and intravascular coronary procedures. Use only the recommended balloon inflation medium. Hydrophilic coating to be wet only with normal saline or water and care must be taken with sharp objects to avoid damage to the hydrophilic coating. Appropriate anticoagulant therapy should be administered by the physician. Precaution should be taken when treating patients with previous stenting within 5mm of target lesion.

 

Potential adverse effects consistent with standard based cardiac interventions include– Abrupt vessel closure – Allergic reaction to contrast medium, anticoagulant and/or antithrombotic therapy-Aneurysm-Arrhythmia-Arteriovenous fistula-Bleeding complications-Cardiac tamponade or pericardial effusion-Cardiopulmonary arrest-Cerebrovascular accident (CVA)-Coronary artery/vessel occlusion, perforation, rupture or dissection-Coronary artery spasm-Death-Emboli (air, tissue, thrombus or atherosclerotic emboli)-Emergency or non-emergency coronary artery bypass surgery-Emergency or non-emergency percutaneous coronary intervention-Entry site complications-Fracture of the guide wire or failure/malfunction of any component of the device that may or may not lead to device embolism, dissection, serious injury or surgical intervention-Hematoma at the vascular access site(s)-Hemorrhage-Hypertension/Hypotension-Infection/sepsis/fever-Myocardial Infarction-Myocardial Ischemia or unstable angina-Pain-Peripheral Ischemia-Pseudoaneurysm-Renal failure/insufficiency-Restenosis of the treated coronary artery leading to revascularization-Shock/pulmonary edema-Slow flow, no reflow, or abrupt closure of coronary artery-Stroke-Thrombus-Vessel closure, abrupt-Vessel injury requiring surgical repair-Vessel dissection, perforation, rupture, or spasm.

 

Risks identified as related to the device and its use: Allergic/immunologic reaction to the catheter material(s) or coating-Device malfunction, failure, or balloon loss of pressure leading to device embolism, dissection, serious injury or surgical intervention-Atrial or ventricular extrasystole-Atrial or ventricular capture.

 

Prior to use, please reference the Instructions for Use for more information on warnings, precautions and adverse events.  https://shockwavemedical.com/IFU

true false Webinar On Demand: Shockwave IVL Within Non-Surgical Facilities Click Here To Watch

To keep you apprised of the latest IVL news, education, and cases, please share your selected interests.